改善治疗历程:预防性药物基因组学在患者照护中的效用
Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
PubMed 文献 · Clin Pharmacol Ther · 2016-11-21
药物基因组学检测临床应用增加但广泛实施仍受限,导致患者经历「治疗历程」。在处方前进行预防性药物基因组学检测可提高药物有效性并降低不良反应风险。
要点
- 处方前预防性药物基因组学检测可提高药物有效性。
- 预防性检测可降低不良反应风险。
- 当前药物基因组学广泛实施受限导致治疗历程。
核心结论
- 预防性药物基因组学检测可提高药物有效性并降低不良反应风险。
主要发现
- 药物基因组学检测临床应用增加但广泛实施仍受限,导致患者经历「治疗历程」。
临床怎么用
- 在处方前进行预防性药物基因组学检测以个体化药物治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacogenomics, studying genetic variation related to drug response, was established decades ago. Today, performing clinical pharmacogenomics testing has increased, creating great potential to improve patient care. Yet widespread implementation of pharmacogenomics in practice is currently limited, resulting in the "therapeutic odyssey" of patients. Preemptive clinical pharmacogenomics testing prior to the time of prescribing is now emerging as an option that could tailor the pharmacotherapy of patients by increasing drug effectiveness while reducing adverse drug reaction risk.
来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。
引用
- Lazaridis KN. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care. Clin Pharmacol Ther. 2016. PMID: 27804107. doi:10.1002/cpt.543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。